DOJ Opioid Leader Flays Pharmacies In Enforcement Vow

Law360 (December 15, 2020, 10:40 PM EST) -- Many pharmacies have ignored their legal duty to prevent the diversion of narcotic painkillers for illicit uses, and related enforcement actions are likely in 2021, one of the U.S. Department of Justice's top opioid attorneys said Tuesday.

Daniel Feith, a deputy assistant attorney general overseeing the DOJ's Consumer Protection Branch, made the comments during a keynote address at the Food and Drug Law Institute's annual enforcement conference for the pharmaceutical industry. The remarks signaled that the federal government will continue to broaden its opioid enforcement beyond drug manufacturers and distributors.

"The Consumer Protection Branch is also going after unlawful actions by...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!